Asia-Pacific Chronic Idiopathic Constipation Drug Market Forecast 2017-2025

Friday, July 21, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, July 20, 2017 /PRNewswire/ -- KEY FINDINGS The Asia-Pacific chronic idiopathic

constipation drug market is anticipated grow at a CAGR of 5.76% during the forecast period of 2017-2025. The revenue generated by the market is expected to rise from $303.4 million in 2016 and reach $
502.4 million
by 2025. Download the full report: https://www.reportbuyer.com/product/5012009/MARKET INSIGHTS The Asian CIC drug market can be segmented by the type of drug and by the type of prescription. The drug lubiprostone is dominating the drug segment closely followed by the drug linaclotide. By prescription type, the over the counter drugs are more popular as they can be obtained without a doctor's prescription. The major driver increasing the growth of the Asian market is the modern dietary habits such as intake of foods rich in animal fats especially dairy products, eggs and meat or foods that have refined sugar and low fiber. Although the market looks promising for the coming years, factors like alternate surgical treatments and the lack of awareness about such drugs in the masses are acting as restraints for market growth. COMPETITIVE INSIGHTS Ferring International Center S.A, Progenics Pharmaceuticals Inc Chugai Pharmaceutical, Theravance Biopharma Inc,Allergens, Synergy Pharmaceuticals, Valeant Pharmaceuticals International, Cosmo Pharmaceuticals Sa, GlaxoSmithKline, Pfizer, Daiichi Sankyo Co Ltd, Ironwood Pharmaceuticals Inc, , Salix Pharmaceuticals Ltd, Roche Holding Ag ,Merck Sharp & Dohme, Bayer Ag, and Sucampo Pharmaceuticals Inc, are some of the leading companies in the market. Download the full report: https://www.reportbuyer.com/product/5012009/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.comFor more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com

View original content:http://www.prnewswire.com/news-releases/asia-pacific-chronic-idiopathic-constipation-drug-market-forecast-2017-2025-300492064.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook